The Issue: As Congress continues its work on both marijuana and cannabidiol (CBD), including Delta-9 products, policymakers should draw on the expertise and experience of the alcohol industry and public health leaders.

Why It Matters: The lack of clarity in federal policy on THC and CBD products creates significant challenges for businesses seeking to take part in regulated commercial activity. Additionally, this lack of clarity continues to create workplace challenges.

We Encourage Congress To:

• Maintain the integrity of the existing alcohol regulatory structure and provide greater clarity to stakeholders on federal oversight of the marijuana and CBD marketplace.
• Draw on the expertise and experience of the alcohol industry and public health leaders as it considers federal oversight of the industry.